معرفی
Jacqueline Flynn serves as an Adjunct Research Fellow at Monash University's Centre for Inflammatory Disease within Monash Health. She leads a laboratory in the Rheumatology Research Division where she develops novel therapeutics for Systemic Lupus Erythematosus (SLE). In addition to her primary appointment, she holds honorary fellowships at both the Burnet Institute and RMIT University, demonstrating her collaborative approach to immunological research. Her work significantly contributes to the United Nations Sustainable Development Goals, particularly in improving health outcomes globally.
Dr. Flynn's research expertise spans human immunology, clinical trials, and translational research with a specific focus on chronic inflammatory diseases. Her laboratory employs fundamental biological techniques to translate research findings into practical applications that decrease disease burden worldwide. Her work has made substantial contributions to developing new vaccine delivery systems, influencing critical health policy changes, and expanding global medical knowledge. She has developed expertise in several key areas including autoimmune diseases, virology, immunology and inflammation, with particular focus on T cells, dendritic cells, and macrophages.
Her publication record demonstrates a strong research trajectory with significant contributions in both autoimmune disease research (particularly SLE/lupus) and HIV immunology. Her work on GILZ (Glucocorticoid-Induced Leucine Zipper) protein has revealed its critical role as a regulator of type I interferon production in lupus, representing a potential therapeutic checkpoint. Her publications show consistent output with multiple high-impact papers in recent years, reflecting active research programs in both autoimmune diseases and HIV pathogenesis.
Dr. Flynn has received numerous prestigious awards including the AFAS Fellowship, Harold Mitchell Foundation Fellowship, Ian Potter Foundation Scholarship, RMIT Vice Chancellor's Postdoctoral Fellowship, and Veski Fellowship. These competitive fellowships recognize her contributions to immunological research and her potential as an independent investigator.
As an active research mentor, Dr. Flynn accepts PhD students through Monash University's Supervisor Connect program. She has successfully secured research funding, including a 2019 Arthritis Australia grant for the development of a novel SLE therapeutic where she served as Primary Chief Investigator. Her community engagement includes public events such as the Flu Vaccination Cafe at Melbourne Town Hall and Day of Immunology Tours, demonstrating her commitment to public health education.
Dr. Flynn's laboratory focuses on developing novel therapeutics for SLE while also investigating fundamental mechanisms of immune regulation. Her dual research interests in autoimmune diseases and HIV pathogenesis reflect a comprehensive approach to understanding immune system dysregulation across different disease contexts. Her work bridges basic immunological mechanisms with translational applications aimed at improving patient outcomes globally.
